CLOSE X
Tatva Chintan Pharma Chem Ltd.
Issue Open Date 16-Jul-21  
Issue Closing Date 20-Jul-21  
Application Money 100  
Allotment Money  
Price Band () 1073 - 1083  
Minimum Bid Quantity. 13  
Issue Size (Shares) 4616804  
Market Lot 1  
Objective

1. Funding capital expenditure requirements for expansion of our Dahej Manufacturing Facility.2. Funding capital expenditure requirements for upgradation at our R&D facility in Vadodara.3. General corporate purposes.

Business Description

We are a specialty chemicals manufacturing company engaged in the manufacture of a diverse portfolio ofstructure directing agents (“SDAs”), phase transfer catalysts (“PTCs”), electrolyte salts for super capacitorbatteries and pharmaceutical and agrochemical intermediates and other specialty chemicals (“PASC”). OurCompany is the largest and only commercial manufacturer of SDAs for zeolites in In...

Promoter's Holding
Total Share Capital   20087500  
Offered to Public   4616804  
Promoter's Holding (Pre-Issue)   100  
Promoter's Holding (Post-Issue)   79.17  
Address
Address :Plot No 502/17
G I D C Estate
Ankleshwar
City :Bharuch, State :Gujarat Pincode :393002 Phone :07574848533 / 34 Email : chintan@tatvachintan.com Website : www.tatvachintan.com
Registrar
Link Intime India Pvt Ltd.
C 101
247 Park
LBS Marg
Vikhroli (West)
Mumbai
Listed at
BSE, NSE
Lead Manager
ICICI Securities Ltd
JM Financial Ltd.
Promoters
Ajaykumar Mansukhlal Patel
Chintan Nitinkumar Shah
Shekhar Rasiklal Somani
BNK Securities Pvt. Ltd

CIN No.:U67120WB1995PTC071182 (ISO 90001:2015 & ISO 27001:2013 Certified Company)

Registered Office: Mayfair Tower, 2,Palm Avenue,Kolkata-700 019

Tel:+91-33-4602-2160/61/62/63 Email:contact@bnkcapital.com

BNK Securities Pvt Ltd. MEMBERS OF NSE, BSE AND MSEI SEBI Registration no: INZ000220037

SEBI Registration No: MB / INM000011641 (Category I Merchant Banker), Research Analyst. Reg no INH300003520

DEPOSITORY PARTICIPANT SEBI Registration No-In-DP-673-2022, CDSL DP ID - 12060500.

AMFI certified Mutual Fund Distributor Registration No: ARN–86507

For any grievances, investors can contact at: grievance@bnkstockline.com, Tel:+91-33-4602-2160/61/62/63

 ©  Copyrights 2022, BNK Capital Group All Rights Reserved

Designed & Developed - Accord Fintech Pvt. Ltd.